Effective Sunscreen Ingredients and Cutaneous Irritation in Patients with Rosacea

Cutis

Volumn 61, Issue 6, 1998, Pages 344-346

  Nichols, Khanh ^a,c   Desai, Nayan ^b   Lebwohl, Mark G ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Chattem Inc   (United States)

^c MOUNT SINAI HOSPITAL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOLOGY; INCIDENCE; IRRITANT DERMATITIS; PROGNOSIS; RISK FACTOR; ROSACEA;

DERMATITIS, IRRITANT; DOUBLE-BLIND METHOD; HUMANS; INCIDENCE; PROGNOSIS; RISK FACTORS; ROSACEA; SUNSCREENING AGENTS;

EID: 0032087405     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Federal Register, Department of Health and Human Services, Food and Drug Administration. Skin Protectant Drug Products for Over-the-Counter Human Use, Diaper Rash Products; Proposed Rule. 55: 25230, 1990.
2. Fisher AA: Sunscreen dermatitis due to glyceryl PABA: significance of cross-reactions to this PABA ester. Cutis 18: 495-500, 1976.